Proportion of Extrapulmonary MDR-TB Confirmed by GeneXpert® in Dr. Hasan Sadikin General Hospital, West Java, Indonesia Year 2012–2021
Downloads
As the third-highest country with tuberculosis (TB) incidence worldwide in 2020, Indonesia has increasing TB cases resistant to various anti-TB therapy or multidrug-resistant (MDR)-TB, and ranked fifth for its high incidence reported in Global Tuberculosis Report 2020. Moreover, extrapulmonary TB (EPTB) is rising, and data studies on EPTB with MDR-TB in Indonesia are scarce. This study aimed to explore the proportion of extrapulmonary MDR-TB among TB cases in Dr. Hasan Sadikin General Hospital Bandung, West Java, Indonesia. A descriptive retrospective and cross-sectional study design were conducted, retrieving medical records from all suspect MDR-TB adult patients examined by GeneXpert®, at Dr. Hasan Sadikin General Hospital Bandung, West Java period 2012–2021. Those with EPTB were further analyzed, and the demographic data was collected as well as clinical history, behavioral history, sites of extrapulmonary MDR-TB, and drug resistance. Of a total 7,013 TB cases, 1,900 (27.1%) were MDR-TB cases, of whom 0.08% (n6) were extrapulmonary MDR-TB cases and 0.16% (n11) were combined with PTB. The main characteristics of cases with extrapulmonary MDR-TB were median age 27-year-old (range 25–34), male gender (64.7%), underweight BMI (84.6%), and predominantly were primary cases (35.3%). The anti-TB drug resistance in MDR-TB were pre-XDR-TB (11.7%), XDR-TB (5.6%), MDR-TB (42%), and RR-TB (40.7%). Although the proportion of extrapulmonary MDR-TB among all TB cases is small (0.2%), this disease can't be ignored and has a great potential to be explored. Most of them are rifampicin-resistant. Further studies need to include a larger population to have more overview of MDR-TB with EPTB.
Churchyard G, Kim P, Shah NS, Rustomjee R, Gandhi N, Mathema B, et al. What We Know about Tuberculosis Transmission: An Overview. J Infect Dis. 2017;216(Suppl 6):S629–35.
Barberis I, Bragazzi NL, Galluzzo L, Martini M. The history of tuberculosis: From the first historical records to the isolation of Koch's bacillus. J Prev Med Hyg. 2017;58(1):E9–12.
Global Tuberculosis Report 2021. Geneva: World Health Organization; 2021. 1–57 p.
Kementerian Kesehatan RI. TB MDR [Internet]. 2021 [cited 2021 Nov 8]. Available from: https://tbindonesia.or.id/pustaka-tbc/informasi/teknis/tb-mdr/
WHO. Global tuberculosis report 2020 [Internet]. Geneva; 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf
Kementerian Kesehatan RI. Peraturan Menteri Kesehatan Republik Indonesia No. 67 Tahun 2016 tentang Penanggulangan Tuberkulosis. Peraturan Menteri Kesehatan. [Internet]. Journal of Chemical Information and Modeling Indonesia; 2016. Available from: https://www.kncv.or.id/publikasi/229-permenkes-no-67-tahun-2016-penanggulangan-tuberkulosis.html
Kementerian Kesehatan RI. Petunjuk Teknis Penatalaksanaan Tuberkulosis Resistan Obat 2020 [Internet]. Jakarta; 2020. 978–979 p. Available from: https://tbindonesia.or.id/wp-content/uploads/2021/06/TBRO_Buku-Juknis-Tuberkulosis-2020-Website.pdf
Sahiratmadja E, Mega G, Andriyoko B, Parwati I. Performance of Xpert® MTB/RIF in Detecting Multidrug-Resistance Tuberculosis in West Java, Indonesia. MKB. 2020;52(2):99–106.
Hamusse SD, Teshome D, Hussen MS, Demissie M, Lindtjí¸rn B. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia. BMC Public Health [Internet]. 2016;16(1):1–10. Available from: http://dx.doi.org/10.1186/s12889-016-3210-y
Qian X, Nguyen DT, Lyu J, Albers AE, Bi X, Graviss EA. Risk factors for extrapulmonary dissemination of tuberculosis and associated mortality during treatment for extrapulmonary tuberculosis article. Emerg Microbes Infect [Internet]. 2018;7(1):1–14. Available from: http://dx.doi.org/10.1038/s41426-018-0106-1
Pang Y, An J, Shu W, Huo F, Chu N, Gao M, et al. Epidemiology of extrapulmonary tuberculosis among inpatients, China, 2008-2017. Emerg Infect Dis. 2019;25(3):457–64.
Sinha P, Srivastava GN, Gupta A, Anupurba S. Association of risk factors and drug resistance pattern in tuberculosis patients in North India. J Glob Infect Dis. 2017;9(4):139–45.
Rodriguez-Takeuchi SY, Renjifo ME, Medina FJ. Extrapulmonary tuberculosis: Pathophysiology and imaging findings. Radiographics. 2019;39(7):2023–37.
World Health Organization. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis [Internet]. Wold Health Organization. 2020. CC BY-NC-SA 3.0 IGO. Available from: https://www.who.int/publications/i/item/meeting-report-of-the-who-expert-consultation-on-the-definition-of-extensively-drug-resistant-tuberculosis
Raveendran R, Oberoi JK, Wattal C. Multidrug-resistant pulmonary & extrapulmonary tuberculosis: A 13 years retrospective hospital-based analysis. Indian J Med Res. 2015;142(NOVEMBER):575–82.
Kementerian Kesehatan RI. Profil Kesehatan Indonesia Tahun 2019 [Internet]. Jakarta: Sekretariat Jenderal; 2019. Available from: https://pusdatin.kemkes.go.id/resources/download/pusdatin/profil-kesehatan-indonesia/Profil-Kesehatan-indonesia-2019.pdf
Lu Z, Jiang W, Zhang J, Lynn HS, Chen Y, Zhang S, et al. Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China. PLoS One. 2019;14(11):1–14.
Mason PH, Snow K, Asugeni R, Massey PD, Viney K. Tuberculosis and gender in the Asia-Pacific region. Aust N Z J Public Health. 2017;41(3):227–9.
Wang S, Tu J. Nomogram to predict multidrug-resistant tuberculosis. Ann Clin Microbiol Antimicrob [Internet]. 2020;19(1):1–8. Available from: https://doi.org/10.1186/s12941-020-00369-9
Staff WB. Population, male (% of total population) - Indonesia [Internet]. 2019 [cited 2021 Nov 8]. Available from: https://data.worldbank.org/indicator/SP.POP.TOTL.MA.ZS?end=2020&locations=ID&start=2012
Dobner J, Kaser S. Body mass index and the risk of infection - from underweight to obesity. Clin Microbiol Infect [Internet]. 2018;24(1):24–8. Available from: https://doi.org/10.1016/j.cmi.2017.02.013
Ali MH, Alrasheedy AA, A HM, Kibuule D, Go. Predictors of Multidrug-Resistant Tuberculosis. 2019;1–11.
Baghaei P, Tabarsi P, Javanmard P, Farnia P, Marjani M, Moniri A, et al. Impact of diabetes mellitus on tuberculosis drug resistance in new cases of tuberculosis. J Glob Antimicrob Resist [Internet]. 2016;4:1–4. Available from: http://dx.doi.org/10.1016/j.jgar.2015.11.006
Saktiawati AMI, Subronto YW. Influence of Diabetes Mellitus on the Development of Multi Drug Resistant-Tuberculosis in Yogyakarta. Acta Med Indones. 2018;50(1):11–7.
Restrepo BI. Diabetes and Tuberculosis. Schlossberg D, editor. Microbiol Spectr [Internet]. 2016 Dec 23;4(6):519–22. Available from: https://journals.asm.org/doi/10.1128/microbiolspec.TNMI7-0023-2016
Seegert AB, Rudolf F, Wejse C, Neupane D. Tuberculosis and hypertension”a systematic review of the literature. Int J Infect Dis. 2017;56:54–61.
Peltzer K, Pengpid S. The Prevalence and Social Determinants of Hypertension among Adults in Indonesia: A Cross-Sectional Population-Based National Survey. Int J Hypertens. 2018;2018.
Singh A, Prasad R, Balasubramanian V, Gupta N. Drug-resistant tuberculosis and hiv infection: Current perspectives. HIV/AIDS - Res Palliat Care. 2020;12:9–31.
Balbi GGM, MacHado-Ribeiro F, Marques CDL, Signorellia F, Levy RA. The interplay between tuberculosis and systemic lupus erythematosus. Curr Opin Rheumatol. 2018;30(4):395–402.
RI KDN. Visualisasi Data Kependudukan [Internet]. 2021. Available from: https://gis.dukcapil.kemendagri.go.id/peta/
Cheng Q, Xie L, Wang L, Lu M, Li Q, Wu Y, et al. Incidence Density and Predictors of Multidrug-Resistant Tuberculosis Among Individuals With Previous Tuberculosis History: A 15-Year Retrospective Cohort Study. Front Public Heal. 2021;9(May):1–14.
Desai U, Joshi J. Extrapulmonary drug-resistant tuberculosis at a drug-resistant tuberculosis center, Mumbai: Our experience – Hope in the midst of despair! Lung India [Internet]. 2019;36(1):3. Available from: http://www.lungindia.com/text.asp?2019/36/1/3/249161
Copyright (c) 2022 Indonesian Journal of Tropical and Infectious Disease
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Indonesian Journal of Tropical and Infectious Disease (IJTID) is a scientific peer-reviewed journal freely available to be accessed, downloaded, and used for research. All articles published in the IJTID are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which is under the following terms:
Attribution ” You must give appropriate credit, link to the license, and indicate if changes were made. You may do so reasonably, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
